H.Res.576 - Supporting efforts to increase childhood cancer awareness, treatment, and research.106th Congress (1999-2000)
Text: H.Res.576 — 106th Congress (1999-2000)
Bill text available as:
Engrossed in House (09/27/2000)
Formatting necessary for an accurate reading of this legislative text may be shown by tags (e.g., <DELETED> or <BOLD>) or may be missing from this TXT display. For complete and accurate display of this text, see the PDF or HTML/XML.
[Congressional Bills 106th Congress] [From the U.S. Government Printing Office] [H. Res. 576 Engrossed in House (EH)] In the House of Representatives, U.S., September 27, 2000. Whereas an estimated 12,400 children will be diagnosed with cancer in the year 2000; Whereas cancer is the leading cause of death by disease in children under age 15; Whereas an estimated 2,300 children will die from cancer in the year 2000; Whereas the incidence of cancer among children in the United States is rising by about one percent each year; Whereas 1 in every 330 Americans develops cancer before age 20; Whereas approximately 8 percent of deaths of those between 1 and 19 years old are caused by cancer; Whereas a number of opportunities for childhood cancer research remain unfunded or underfunded; Whereas limited resources for childhood cancer research hinder the recruitment of investigators and physicians to pediatric oncology; Whereas peer-reviewed clinical trials are the standard of care for pediatrics and have improved cancer survival rates among children; and Whereas a recent study indicates that, based on parental reports, 89 percent of children with cancer experienced substantial suffering in the last month of life: Now, therefore, be it Resolved, That it is the sense of the House of Representatives that Congress should support-- (1) public and private sector efforts to promote awareness about the incidence of cancer among children, the signs and symptoms of cancer in children, and treatment options; (2) increased public and private investment in childhood cancer research to improve prevention, diagnosis, treatment, and long-term survival; (3) policies that provide incentives to encourage medical trainees and investigators to enter the field of pediatric oncology; (4) policies that provide incentives to encourage the development of drugs and biologics designed to treat pediatric cancers; (5) policies that encourage participation in clinical trials; and (6) medical education curricula designed to improve pain management for cancer patients. Attest: Clerk.